Table 2.
Treatment Exposure and Administration: Daratumumab, N = 348a
| Variable | Median (Range) |
|---|---|
| Duration of treatment, mo | 1.9 (0.03‐6.0) |
| No. treatment cycles | 3 (1‐7) |
| Total no. daratumumab infusions | 8 (1‐17) |
| Relative dose intensity, % | 100.7 (64.9‐108.9) |
| Duration of infusions, h | |
| First infusion | 7.4 (1.0‐24.0) |
| Second infusion | 4.4 (2.9‐16.3) |
| All subsequent infusions | 3.5 (0.8‐26.1) |
a
Doses include daratumumab delivered as part of investigational supply and not commercial supply. The duration of infusion includes both actual infusion time and interruption time, if any.